T, v. D., F, B., A, C., M, F., & B, S. (2023). Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose? Translational vision science & technology, 12(4), 9. https://doi.org/10.1167/tvst.12.4.9
Chicago Style (17th ed.) CitationT, van Donge, Brizzi F, Caruso A, Fueth M, and Steiert B. "Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?" Translational Vision Science & Technology 12, no. 4 (2023): 9. https://doi.org/10.1167/tvst.12.4.9.
MLA (9th ed.) CitationT, van Donge, et al. "Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?" Translational Vision Science & Technology, vol. 12, no. 4, 2023, p. 9, https://doi.org/10.1167/tvst.12.4.9.